Position in PCVX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$15,970,636
+$5,495 QoQ
Shares Held
274,740
0.0% QoQ
Ownership
0.185%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#64
of 329 holders
Holding Since
Jun 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Woodline Partners LP holds $4,400,572,274 across 197 Biotechnology names. PCVX ranks #72 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,002,863 | $375,096,182 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
1,414,173 | $173,349,326 | |
| 3 | TNGX |
Tango Therapeutics, Inc.
|
4,000,567 | $125,057,724 | |
| 4 | BHVN |
Biohaven Ltd.
|
7,660,280 | $113,984,966 | |
| 5 | COGT |
Cogent Biosciences, Inc.
|
2,603,162 | $100,742,369 | |
| 6 | CYTK |
Cytokinetics Inc
|
1,100,708 | $93,769,314 | |
| 7 | RCUS |
Arcus Biosciences, Inc.
|
3,007,798 | $92,730,412 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
2,500,673 | $88,498,817 |
All Filings in PCVX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,970,636 | 274,740 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $15,965,141 | 274,740 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $12,676,503 | 274,740 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $8,896,435 | 246,986 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,504,535 | 200,078 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $41,980,699 | 1,111,777 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $91,758,674 | 1,120,922 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $126,147,795 | 1,103,945 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $53,378,245 | 706,903 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $26,893,920 | 393,704 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $24,702,442 | 393,351 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $19,403,650 | 380,613 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $19,499,372 | 390,456 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $9,370,000 | 250,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $11,987,500 | 250,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $4,714,296 | 196,429 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $10,147,210 | 466,324 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $2,317,050 | 97,396 | Shares | Sole | 2022-02-14 | |
| 2020-06-30 | $727,851 | 23,026 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||